Want to work in health data? Registry recruiting for three new posts
The IBD Registry is recruiting three important posts to help its next phase of growth as one of the largest IBD registries in Europe. We are recruiting a Data Analytics Manager, a Projects and Operations Manager and a Data Analyst/ Developer.
The roles will support the Registry’s activities as a partner in a group led by Cambridge University Hospitals on a 3 year project funded by Health Data Research UK to link and make accessible diverse datasets in a Hub for researchers.
The project will involve the FHIR transformation of our existing dataset and linkage of it with Bioresource IBD dataset and also with the key NHS HES and electronic Prescribing datasets. This is a national project very much at the leading edge, looking to transform the landscape for researchers and the data they need for their work.
More information on the roles including job descriptions available at the links below:
Data and Analytics Manager (closes 24th Nov 2019 – but we encourage early application as we may close early if the right candidate is found)
Data Analyst/Developer (closes 24th November 2019 – but we encourage early application as we may close early if the right candidate is found)
Projects and Operations Manager (closes 1st December 2019 – but we encourage early application as we may close early if the right candidate is found)
For any queries please contact [email protected]
Find out more about:
The IBD Registry has published its first Annual Report on the Use of Biologics for Inflammatory Bowel Diseases for the year 2018-19. The report includes the cumulative results to January 2019 from April 2016 when the Registry assumed the role of supporting the National Audit of Biological Therapies from the Royal College of Physicians.
A £5m grant has been awarded by Health Data Research UK (HDR UK) to establish a health data research hub for inflammatory bowel disease (IBD). The IBD hub, to be known as Gut Reaction – The Health Data Research Hub for Inflammatory Bowel Disease, will bring together...
The IBD Registry is inviting UK IBD clinical centres to participate in a post-marketing safety study of patients using Zessly (infliximab), a biosimilar available for the treatment of Inflammatory Bowel Disease (IBD). This study is facilitated by the Registry on...
The IBD Registry is delighted a presentation prepared by the Registry’s Analytics Hub at the University of Liverpool featured in the British Society of Gastroenterology Annual Meeting in Glasgow. The Audit of biological therapy for IBD - Shawihdi et al Poster BSG 2019...
The IBD Registry says the launch of the new IBD Standards, the first for six years, at the BSG Annual meeting in Glasgow today, Thursday, 20th June, will provide a catalyst to drive quality in inflammatory bowel disease (IBD). The IBD Standards, produced by IBD UK, an...